InvestorsHub Logo

Inoviorulez

12/31/18 9:16 PM

#32603 RE: Pro140 #32597

Yes based on the notion that Pro-140 being approved even as a combo would eat into Gilead's market share. Even then don't Pfizer and Merck needs the CCR5 patents that Dr. Pestell owns for CCR5 antognists in cancer? many avenues in my opinion.